NALPAIN

This brand name is authorized in Estonia, France, Poland

Active ingredients

The drug NALPAIN contains one active pharmaceutical ingredient (API):

1 Nalbuphine
UNII ZU4275277R - NALBUPHINE HYDROCHLORIDE

Nalbuphine is an opioid with kappa-agonistic and mu-antagonistic properties. Beside the essential agonistic (analgesic) effect nalbuphine has antagonistic effects of about a fourth of nalorfine and ten times of pentazocine.

Read about Nalbuphine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NALPAIN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02AF02 Nalbuphine N Nervous system → N02 Analgesics → N02A Opioids → N02AF Morphinan derivatives
Discover more medicines within N02AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1275724
Country: FR Base de donnรฉes publique des mรฉdicaments Identifier(s): 66352301
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100191043

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.